Welby

Welby EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Welby (4438.T) as of Oct 29, 2026 is -6.68. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -2.30 — a change of 190.49% (lower).

EV/FCF

-6.68

YoY

190.49%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Welby is 2025 -6.68 . EV/FCF (Enterprise Value to Free Cash Flow) of Welby was 2024 -2.30 . It decreases by 190.49% lower compared to the previous year.

The Welby EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-236.85 JPY
Jan 1, 2019
-4.90 JPY
Jan 1, 2020
-8.06 JPY
Jan 1, 2021
-11.95 JPY
Jan 1, 2022
-10.23 JPY
Jan 1, 2023
-8.16 JPY
Jan 1, 2024
-2.30 JPY
Jan 1, 2025
-6.68 JPY
The Welby EV/FCF history
YEAREV/FCFYoY
-6.68+190.49%
-2.30-71.81%
-8.16-20.30%
-10.23-14.39%
-11.95+48.35%
-8.06+64.60%
-4.90-97.93%
-236.85+515.32%
-38.49+142.09%
-15.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Welby Stock analysis

What does Welby do? Welby, Inc. generates revenue through its disease solution service, developed for pharmaceutical companies to establish patient health record platforms. The company also offers Welby My Carte, a cloud service supporting self-management of patients' living habits for conditions like diabetes and hypertension. Pharmaceutical companies purchase the disease solution service, while patients and healthcare providers utilize Welby My Carte for managing chronic conditions. The firm focuses on medical field applications, targeting pharmaceutical firms and end-users seeking health management tools. The disease solution service involves creating PHR platforms tailored to pharmaceutical companies' needs, while Welby My Carte provides a direct consumer-facing solution for managing health habits. Pharmaceutical companies are the primary B2B buyers, and patients using the service for diabetes or hypertension management represent the end-user segment. The company's revenue streams are derived from both enterprise contracts and consumer subscriptions for its health management tools. Welby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Welby stock

EV/FCF (Enterprise Value to Free Cash Flow) of Welby is -6.68 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Welby changed from -2.30 to -6.68, representing a 190.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Welby since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Welby with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Welby

All Key Metrics — Welby